Robert Armstrong
21Patents
7h-index
15Co-inventors
66Inventor score
Filing activity: Apr 17, 1995 → Mar 29, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6270980A | Rapid methods for identifying modifiers of cellular apoptosis activity | Physics | 19 | Expired |
| US8357690B2 | Methods of treatment using combination therapy | Human Necessities | 19 | Active |
| US5786173A | MCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of use | Human Necessities | 12 | Expired |
| US6251614A | Rapid methods for identifying modifiers of cellular apoptosis activity | Physics | 12 | Expired |
| US8566579B2 | Obfuscated authentication systems, devices, and methods | Electricity | 10 | Active |
| US5851815A | MCH4 and MCH5, apoptotic proteases | Human Necessities | 8 | Expired |
| US5590819A | Vehicle mountable auxiliary water tank | Performing Operations; Transporting | 7 | Expired |
| US8836218B2 | Methods of treatment using combination therapy | Human Necessities | 2 | Active |
| US6518032B1 | Rapid methods for identifying modifiers of cellular apoptosis activity | Physics | 2 | Expired |
| US10409994B1 | FPGA/ASIC framework and method for requirements-based trust assessment | Physics | 1 | Active |
| US6462175B1 | Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use | Chemistry; Metallurgy | 1 | Expired |
| US6897296B2 | Antibody that specifically binds an Mch5 polypeptide | Human Necessities | 0 | Expired |
| US10583113B2 | Cromolyn compositions for treatment of pulmonary fibrosis | Human Necessities | 0 | Active |
| US10596146B2 | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US10561635B2 | Cromolyn compositions for treatment of pulmonary fibrosis | Human Necessities | 0 | Active |
| US10265296B2 | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US6730779B2 | Antibody that specifically binds an Mch4 polypeptide | Human Necessities | 0 | Expired |
| US6716960B2 | Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use | Chemistry; Metallurgy | 0 | Expired |
| US10626832B2 | Fluid delivery port of an integral intake manifold | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US6287795A | Mch4 and Mch5, apoptotic protease, nucleic acids encoding and methods of use | Human Necessities | 0 | Expired |
| US6686459B1 | Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.